TSLP and asthma: As shown in Figure 3, serum TSLP was the only biomarker that exhibited a statistically significant increase in acute exacerbation and persistent asthma compared to remission and control groups (P<0.01, Figure 3A), highlighting its potential prognostic value in pediatric Th2-high asthma.